Data / Form D filings / Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc.: Form D filings
Pelthos Therapeutics Inc., a pharmaceuticals company in Durham, NC, filed 4 Form D notices with the SEC between 2024 and 2025. The latest, on November 19, 2025, reports $18 million sold of a $18 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, Durham, NC, 27703
- Phone
- (919) 908-2400
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1919246
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | New notice | $18,000,000 | $18,000,000 | 8 | Nov 6, 2025 | sec.gov | |
| Jul 10, 2025 | New notice | $50,100,000 | $50,100,000 | 13 | Jul 1, 2025 | sec.gov | |
| Aug 6, 2024 | New notice | $30,000,000 | $0 | $30,000,000 | 1 | Yet to occur | sec.gov |
| Aug 6, 2024 | New notice | $750,000 | $750,000 | 1 | Jul 24, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Pauls | Director | |
| Peter Greenleaf | Director | |
| Richard Baxter | Director | |
| Richard Malamut | Director | |
| Todd Davis | Director | |
| Francis Knuettel II | Executive Officer | |
| Sai Rangarao | Executive Officer | |
| Scott Plesha | Executive Officer, Director | |
| Ezra Friedberg | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pelthos Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.